Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jessica Paulicelli
Observed names:
J Paulicelli,
J. Paulicelli,
Paulicelli Jessica
Institutions:
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0009-0008-8361-9605
Observed ORCID:
0009-0008-8361-9605
OpenAlex ID:
A5012455513
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
2022
·
Alessandra Vergori
, Alessandro Cozzi Lepri
, et al.
·
Nature Communications
·
101
PDF
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study
2024
·
Valentina Mazzotta
, Alessandro Cozzi Lepri
, et al.
·
EClinicalMedicine
·
44
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox
2023
·
Valentina Mazzotta
, Alessandro Cozzi‐Lepri
, et al.
·
Journal of Medical Virology
·
37
Viral load decrease in SARS‐CoV‐2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents
2022
·
Valentina Mazzotta
, Alessandro Cozzi Lepri
, et al.
·
Journal of Medical Virology
·
33
Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital
2022
·
Annalisa Mondi
, Roberta Gagliardini
, et al.
·
Journal of Infection
·
28
PDF
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort
2025
·
Roberta Gagliardini
, Sara De Benedittis
, et al.
·
Journal of Antimicrobial Chemotherapy
·
22
Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study)
2023
·
Marta Camici
, Roberta Gagliardini
, et al.
·
International Journal of Antimicrobial Agents
·
17
Kinetics of the humoral and cellular immune response up to 1 year from mpox virus infection
2025
·
Valentina Mazzotta
, Giulia Matusali
, et al.
·
Clinical Microbiology and Infection
·
16
PDF
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort
2024
·
Antonella d’Arminio Monforte
, Alessandro Tavelli
, et al.
·
Journal of Antimicrobial Chemotherapy
·
15
PDF
Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH
2022
·
Roberta Gagliardini
, Alessandra Vergori
, et al.
·
Journal of Clinical Medicine
·
13
PDF
Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis
2023
·
Giulia Del Duca
, Alessandro Tavelli
, et al.
·
Vaccines
·
12
PDF
SARS-CoV-2 Nasopharyngeal Viral Load in Individuals Infected with BA.2, Compared to Alpha, Gamma, Delta and BA.1 Variants: A Single-Center Comparative Analysis
2022
·
Ilaria Mastrorosa
, Alessandro Cozzi-Lepri
, et al.
·
Journal of Clinical Virology
·
12
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study
2023
·
Antonella D’arminio Monforte
, Alessandro Tavelli
, et al.
·
Journal of Antimicrobial Chemotherapy
·
11
PDF
Salivary cortisol in long COVID: a marker of broader stress system and circadian rhythm dysregulation
2026
·
Marta Camici
, Marta Franco
, et al.
·
Frontiers in Cellular and Infection Microbiology
·
7
PDF
Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route
2024
·
Valentina Mazzotta
, Pierluca Piselli
, et al.
·
Vaccines
·
7
PDF
Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study
2024
·
Stefania Cicalini
, Simone Lanini
, et al.
·
Pharmaceuticals
·
7
PDF
Humoral and T-cell responses following MVA-BN booster vaccination against mpox virus clades Ib and IIb
2025
·
Mazzotta Valentina
, Matusali Giulia
, et al.
·
Journal of Infection
·
6
PDF
Sarilumab Plus Standard of Care Versus Standard of Care for the Treatment of Severe COVID-19: A Phase 3, Randomized, Open-Labeled, Multi-Center Study (ESCAPE Study)
2022
·
Ilaria Mastrorosa
, Roberta Gagliardini
, et al.
·
EClinicalMedicine
·
6
Impact of switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate to bictegravir/emtricitabine/tenofovir alafenamide on psychiatric symptoms and neurocognition
2024
·
Alessandra Vergori
, Giulia Del Duca
, et al.
·
AIDS
·
5
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort
2025
·
Alessandra Vergori
, Alessandro Cozzi-Lepri
, et al.
·
Journal of Antimicrobial Chemotherapy
·
4
Prevalence of Circulating Autoantibodies Against G-Protein-Coupled Receptors as Potential Biomarkers for Long COVID: Preliminary Investigations
2026
·
Marta Camici
, Marta Franco
, et al.
·
International Journal of Molecular Sciences
·
3
Immune Response Against Recent Omicron Sub-Lineages in Persons with HIV Receiving a Protein-Based or mRNA XBB.1.5 SARS-CoV-2 Booster Vaccine
2025
·
Alessandra Vergori
, Giulia Matusali
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era
2024
·
Alessandra Vergori
, Alessandro Cozzi Lepri
, et al.
·
International Journal of Infectious Diseases
·
3
PDF
Did the COVID-19 pandemic shift the landscape of late HIV diagnosis?
2026
·
Giulia Micheli
, Annalisa Mondi
, et al.
·
International Journal of Infectious Diseases
·
2
PDF
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view
2024
·
A Cingolani
, A Tavelli
, et al.
·
Journal of Antimicrobial Chemotherapy
·
2
Show more works
View as search
Works count:
40
Citation count:
420
H-index:
12
I10-index:
13
Year
Topic
Type